Epstein Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns. Viral role in tumor microenvironment

COHEN, M; DE MATTEO, E; NARBAITZ, M; AGOST CARREÑO F; PRECIADO, M. V.; PAOLA ANDREA CHABAY

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.

JOHN WILEY & SONS INC

Lugar: New York; Año: 2013 vol. 132 p. 1572 - 1580

0020-7136

Non-Hodgkin lymphoma represents 6 to 10% of pediatric malignancies, and diffuse large B-cell lymphoma (DLBCL) is one of the 3 major subtypes. The 2008 WHO classification included a new entity, Epstein-Barr virus (EBV)-positive DLBCL of the elderly, affecting patients older than 50 years. It has been demonstrated that EBV may play a role in tumor microenvironment composition, disturbing anti-tumor immune response and disease progression. Since most studies were performed in adults, our aim was to assess EBV presence and latency pattern, as well as T-cell microenvironment in a pediatric DLBCL series of Argentina. The study was conducted on formalin-fixed paraffin-embedded biopsies from 25 DLBCL patients. EBERs expression was performed by in situ hybridization, while EBV gene expression was analyzed using real-time PCR. LMP1, LMP2A, CD3, CD4, CD8 and Foxp3 expression were assessed by immunohistochemistry (IHC). Forty percent of cases showed EBV expression, with a significantly higher incidence among patients younger than 10 years (p=0.018), and with immunosuppressed (p=0.023). T-cell subsets were not altered by EBV presence. Full EBV latency antigen expression (latency type III) was the most frequently pattern observed, together with BZLF1 lytic gene expression. One patient showed II like pattern (LMP1 without LMP2A expression). Based exclusively on IHC, some patients showed latency II/III (EBERs and LMP1 expression) or I (EBERs only). These findings suggest that EBV association in our series was higher than the previously demonstrated for elderly DLBCL and that EBV latency pattern could be more complex from those previously observed. Therefore, EBV could be an important cofactor in pediatric DLBCL lymphomagenesis.